- Home
- LEXX vs GP Comparison
LEXX vs GP Comparison
Compare LEXX & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- GP
- Stock Information
- Founded
- LEXX 2004
- GP 2010
- Country
- LEXX Canada
- GP Canada
- Employees
- LEXX N/A
- GP N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- GP Construction/Ag Equipment/Trucks
- Sector
- LEXX Health Care
- GP Consumer Discretionary
- Exchange
- LEXX Nasdaq
- GP Nasdaq
- Market Cap
- LEXX 25.8M
- GP 21.9M
- IPO Year
- LEXX N/A
- GP 2020
- Fundamental
- Price
- LEXX $1.45
- GP $0.52
- Analyst Decision
- LEXX Strong Buy
- GP Strong Buy
- Analyst Count
- LEXX 1
- GP 2
- Target Price
- LEXX $7.00
- GP $2.33
- AVG Volume (30 Days)
- LEXX 128.9K
- GP 159.4K
- Earning Date
- LEXX 04-08-2025
- GP 03-18-2025
- Dividend Yield
- LEXX N/A
- GP N/A
- EPS Growth
- LEXX N/A
- GP N/A
- EPS
- LEXX N/A
- GP N/A
- Revenue
- LEXX $496,923.00
- GP $20,656,035.00
- Revenue This Year
- LEXX $30.72
- GP N/A
- Revenue Next Year
- LEXX $31.85
- GP $103.69
- P/E Ratio
- LEXX N/A
- GP N/A
- Revenue Growth
- LEXX 77.63
- GP N/A
- 52 Week Low
- LEXX $1.15
- GP $0.45
- 52 Week High
- LEXX $6.85
- GP $2.29
- Technical
- Relative Strength Index (RSI)
- LEXX 43.81
- GP 30.24
- Support Level
- LEXX $1.15
- GP $0.45
- Resistance Level
- LEXX $1.44
- GP $0.77
- Average True Range (ATR)
- LEXX 0.14
- GP 0.05
- MACD
- LEXX 0.01
- GP -0.01
- Stochastic Oscillator
- LEXX 58.82
- GP 21.28
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.